博雅生物2025年上半年净利润同比下降28.68%

Core Viewpoint - Boya Bio announced a revenue of 1.008 billion yuan for the first half of 2025, representing a year-on-year growth of 12.51% while the net profit attributable to shareholders decreased by 28.68% to 225 million yuan [1] Financial Performance - The company's revenue for the first half of 2025 reached 1.008 billion yuan, showing a year-on-year increase of 12.51% [1] - The net profit attributable to shareholders was 225 million yuan, which is a decline of 28.68% compared to the previous year [1] - The net profit after deducting non-recurring gains and losses was 166 million yuan, reflecting a decrease of 36.05% year-on-year [1]